Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Ayala Pharmaceuticals Inc

HC Wainwright Believes Ayala's Initial Cancer Data Is Encouraging

Ayala Pharmaceuticals Inc (NASDAQ:AYALA) reported data from Part A of its Phase 2 (RINGSIDE) trial evaluating AL102 in patients with desmoid tumors on Tuesday. At 16 weeks, one of 13 patients treated with AL102 demonstrated an unconfirmed partial response, which HC Wainwright believes signals encouraging initial activity. HC Wainwright reiterated the Buy rating on the…

Benzinga · Jul 6, 2022

Ayala's Cancer Candidate Shrinks Tumor In Substantially All Patients In Late-Stage Study

Ayala's Cancer Candidate Shrinks Tumor In Substantially All Patients In Late-Stage Study

Ayala Pharmaceuticals Inc (NASDAQ:AYLA) announced interim results from Part A of the ongoing RINGSIDE Phase 2/3 trial evaluating AL102 in desmoid tumors. MRI scans showed decreases in tumor size in most of the 13 patients who had reached the 16-week point. One patient reached an unconfirmed partial response at week 16. AL102 was…

Benzinga · Jul 5, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

1

Coverage From

Benzinga

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play